Cargando…

Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis

Detalles Bibliográficos
Autores principales:	Lopes-Pacheco, Miquéias, Pedemonte, Nicoletta, Kicic, Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895245/ https://www.ncbi.nlm.nih.gov/pubmed/31849681 http://dx.doi.org/10.3389/fphar.2019.01440

Ejemplares similares

Editorial: Special Issue on “Therapeutic Approaches for Cystic Fibrosis”
por: Pedemonte, Nicoletta
Publicado: (2020)

CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis
por: Lopes-Pacheco, Miquéias
Publicado: (2016)

CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
por: Lopes-Pacheco, Miquéias
Publicado: (2020)

Emerging microRNA Therapeutic Approaches for Cystic Fibrosis
por: Bardin, Pauline, et al.
Publicado: (2018)

Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine
por: Pranke, Iwona, et al.
Publicado: (2019)

Use of a Primary Epithelial Cell Screening Tool to Investigate Phage Therapy in Cystic Fibrosis
por: Trend, Stephanie, et al.
Publicado: (2018)

Human Primary Epithelial Cell Models: Promising Tools in the Era of Cystic Fibrosis Personalized Medicine
por: Awatade, Nikhil T., et al.
Publicado: (2018)

Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis
por: Samuel, Chrishan S., et al.
Publicado: (2017)

The Resolution Approach to Cystic Fibrosis Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)

Proteomics and Metabolomics for Cystic Fibrosis Research
por: Liessi, Nara, et al.
Publicado: (2020)

Functional enhancement strategies to potentiate the therapeutic properties of mesenchymal stromal cells for respiratory diseases
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2023)

Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
por: Ribeiro, Carla Maria Pedrosa, et al.
Publicado: (2021)

Innovative Therapeutic Strategies for Cystic Fibrosis: Moving Forward to CRISPR Technique
por: Marangi, Michele, et al.
Publicado: (2018)

Advances in Preclinical In Vitro Models for the Translation of Precision Medicine for Cystic Fibrosis
por: Silva, Iris A. L., et al.
Publicado: (2022)

Proteostasis Regulators in Cystic Fibrosis: Current Development and Future Perspectives
por: Brusa, Irene, et al.
Publicado: (2022)

Pulmonary bacteriophage and cystic fibrosis airway mucus: friends or foes?
por: Ling, Kak-Ming, et al.
Publicado: (2023)

Multi-Omics Approaches: The Key to Improving Respiratory Health in People With Cystic Fibrosis?
por: Lee, Andrew J., et al.
Publicado: (2020)

Animal Models in the Pathophysiology of Cystic Fibrosis
por: Semaniakou, Anna, et al.
Publicado: (2019)

Editorial: New Insights Into Renal Fibrosis and Therapeutic Effects of Natural Products
por: Xu, Ying, et al.
Publicado: (2022)

Enhancing Cystic Fibrosis Immune Regulation
por: van Heeckeren, Anna M., et al.
Publicado: (2021)

Pharmacological Modulation of Ion Channels for the Treatment of Cystic Fibrosis
por: Pinto, Madalena C, et al.
Publicado: (2021)

Pharmacological Correctors of Mutant CFTR Mistrafficking
por: Pedemonte, Nicoletta, et al.
Publicado: (2012)

Editorial: The Challenge of New Therapeutic Approaches for Unmet Therapeutic Needs
por: Rosa, Arianna Carolina, et al.
Publicado: (2020)

Editorial: Eye Pain: Etiology and Therapeutic Approaches
por: Rusciano, Dario, et al.
Publicado: (2022)

Editorial: Sepsis: Basic, Clinical and Therapeutic Approaches
por: Kang, Yan, et al.
Publicado: (2022)

Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis
por: Recchiuti, Antonio, et al.
Publicado: (2019)

CFTR and Ca(2+) Signaling in Cystic Fibrosis
por: Antigny, Fabrice, et al.
Publicado: (2011)

Strategies to circumvent the CFTR defect in cystic fibrosis
por: Becq, Frédéric, et al.
Publicado: (2013)

Personalized or Precision Medicine? The Example of Cystic Fibrosis
por: Marson, Fernando A. L., et al.
Publicado: (2017)

Cystic Fibrosis Lung Disease in the Aging Population
por: Künzi, Lisa, et al.
Publicado: (2021)

Gene therapy for cystic fibrosis: Challenges and prospects
por: Sui, Hongshu, et al.
Publicado: (2022)

Editorial: New Approaches to Tackle EMT and Fibrosis: From Epigenetics to Nanotechnology
por: Battistelli, Cecilia, et al.
Publicado: (2021)

Editorial: Inflammation in Cardiovascular Diseases: Role of the Endothelium and Emerging Therapeutics
por: Qin, Cheng Xue, et al.
Publicado: (2020)

Elucidating the Interaction of CF Airway Epithelial Cells and Rhinovirus: Using the Host-Pathogen Relationship to Identify Future Therapeutic Strategies
por: Ling, Kak-Ming, et al.
Publicado: (2018)

Role of the SLC26A9 Chloride Channel as Disease Modifier and Potential Therapeutic Target in Cystic Fibrosis
por: Balázs, Anita, et al.
Publicado: (2018)

Editorial: Molecular Mechanisms and New Therapeutic Targets in Epithelial to Mesenchymal Transition (EMT) and Fibrosis
por: Battistelli, Cecilia, et al.
Publicado: (2020)

Editorial: New insights into renal fibrosis and therapeutic effects of natural products volume II
por: Chen, Dan-Qian, et al.
Publicado: (2022)

Progress in Model Systems of Cystic Fibrosis Mucosal Inflammation to Understand Aberrant Neutrophil Activity
por: Laucirica, Daniel R., et al.
Publicado: (2020)

TMEM16A in Cystic Fibrosis: Activating or Inhibiting?
por: Kunzelmann, Karl, et al.
Publicado: (2019)

Antimicrobial Treatment of Staphylococcus aureus in Patients With Cystic Fibrosis
por: Esposito, Susanna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lijk87nt9ldk60u53gi12nek1l